Poxviridae Infections - 23 Studies Found
| Completed |
: A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer : Hepatocellular Carinoma : 2012-06-23 : Biological: JX-594 recombinant vaccina GM-CSF Enrolled patients will receive 5 weekly IV infusions on Da |
| Completed |
: Post-licensure Department of Defense (DOD) Screening Accuracy Study in Military Personnel : Smallpox : 2012-02-23 |
| Completed |
: Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults :
: 2011-06-17 :
|
| Enrolling by invitation |
: VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection : Complication of Smallpox Vaccination : 2011-06-14 : Biological: VIGIV VIGIV is licensed in US, by the FDA, for the treatment of complications of smallpox va |
| Completed |
: Safety and Efficacy of CJ Smallpox Vaccine in Previously Vaccinated Healthy Volunteers : Smallpox : 2011-03-15 : Drug: smallpox vaccine CJ-50300 Conventional CJ-50300 2.5 x 100000 pfu/dose vaccination |
| Completed |
: Vaccinia Vaccine (ACAM2000) for the Production of Vaccinia Immune Globulin Intravenous(VIGIV) : Smallpox Vaccination : 2010-07-05 : Biological: ACAM2000 Percutaneous administration of a droplet (2.5µg) of ACAM2000 using a bifurcate |
| Completed |
: A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects : Smallpox : 2010-06-14 :
|
| Completed |
: Safety and Efficacy of CJ Smallpox Vaccine in Healthy Volunteers : Smallpox : 2010-01-24 : Drug: smallpox vaccine CJ-50300 Conventional CJ-50300 2.5 x 100000 pfu/dose vaccination |
| Completed |
: A Long-Term Study of Healthy Adults Vaccinated With One Dose of Smallpox Vaccine (LISTER Strain) : Smallpox : 2009-10-19 |
| Completed |
: Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®) : Smallpox : 2009-06-25 |